|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.24 USD | +1.71% |
|
+8.82% | +3.36% |
| 02-13 | Growth Falls Short of Expectations, Disappointments in Luxury and China... L'Oréal Stumbles but Stays Strong | |
| 02-13 | L'Oreal's Shares Drop After Soft End to the Year | DJ |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.58 | 10.35 | 5 | 4.38 | 3.4 | |||||
Return on Total Capital | 13.7 | 15.18 | 7.23 | 6.22 | 4.97 | |||||
Return On Equity % | 52.7 | 35.99 | 15.72 | 6.97 | -24.69 | |||||
Return on Common Equity | 57.45 | 41.04 | 18 | 7.16 | -24.69 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 76.42 | 75.73 | 71.31 | 71.67 | 73.96 | |||||
SG&A Margin | 57.63 | 55.71 | 60.16 | 61.55 | 66.07 | |||||
EBITDA Margin % | 22.8 | 24.11 | 15.83 | 15.4 | 13.68 | |||||
EBITA Margin % | 19.46 | 20.92 | 12.06 | 11.04 | 8.81 | |||||
EBIT Margin % | 18.78 | 20.01 | 11.15 | 10.12 | 7.89 | |||||
Income From Continuing Operations Margin % | 17.73 | 13.58 | 6.35 | 2.62 | -7.91 | |||||
Net Income Margin % | 17.7 | 13.47 | 6.32 | 2.5 | -7.91 | |||||
Net Avail. For Common Margin % | 17.7 | 13.47 | 6.32 | 2.5 | -7.91 | |||||
Normalized Net Income Margin | 11.24 | 11.93 | 6.46 | 5.36 | 3.87 | |||||
Levered Free Cash Flow Margin | 15.63 | 10.07 | -8.96 | 9.67 | 10.98 | |||||
Unlevered Free Cash Flow Margin | 16.29 | 10.65 | -7.96 | 11.19 | 12.54 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.82 | 0.83 | 0.72 | 0.69 | 0.69 | |||||
Fixed Assets Turnover | 3.68 | 3.91 | 3.32 | 3.14 | 2.84 | |||||
Receivables Turnover (Average Receivables) | 11.2 | 10.65 | 10.33 | 9.82 | 8.8 | |||||
Inventory Turnover (Average Inventory) | 1.67 | 1.59 | 1.55 | 1.72 | 1.76 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.84 | 1.6 | 1.46 | 1.39 | 1.3 | |||||
Quick Ratio | 1.26 | 0.96 | 0.88 | 0.9 | 0.82 | |||||
Operating Cash Flow to Current Liabilities | 0.69 | 0.52 | 0.28 | 0.41 | 0.23 | |||||
Days Sales Outstanding (Average Receivables) | 32.59 | 34.27 | 35.34 | 37.27 | 41.49 | |||||
Days Outstanding Inventory (Average Inventory) | 217.96 | 229.98 | 235.88 | 213.29 | 207.89 | |||||
Average Days Payable Outstanding | 122.71 | 135.87 | 137.85 | 157.3 | 147.7 | |||||
Cash Conversion Cycle (Average Days) | 127.85 | 128.38 | 133.37 | 93.26 | 101.68 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 116.57 | 120.65 | 158.47 | 184.91 | 244.94 | |||||
Total Debt / Total Capital | 53.82 | 54.68 | 61.31 | 64.9 | 71.01 | |||||
LT Debt/Equity | 110.65 | 109.02 | 137.37 | 168.76 | 234.36 | |||||
Long-Term Debt / Total Capital | 51.09 | 49.41 | 53.15 | 59.23 | 67.94 | |||||
Total Liabilities / Total Assets | 68.38 | 69.24 | 72.59 | 75.49 | 80.57 | |||||
EBIT / Interest Expense | 17.61 | 21.26 | 6.96 | 4.18 | 3.17 | |||||
EBITDA / Interest Expense | 25.94 | 30.53 | 12.61 | 8.29 | 7.68 | |||||
(EBITDA - Capex) / Interest Expense | 22.25 | 24.3 | 8.68 | 5.86 | 5.99 | |||||
Total Debt / EBITDA | 1.8 | 1.52 | 3.16 | 3.14 | 3.46 | |||||
Net Debt / EBITDA | 0.7 | 0.74 | 1.91 | 2.05 | 2.39 | |||||
Total Debt / (EBITDA - Capex) | 2.1 | 1.91 | 4.6 | 4.44 | 4.43 | |||||
Net Debt / (EBITDA - Capex) | 0.81 | 0.93 | 2.77 | 2.9 | 3.06 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 13.44 | 9.39 | -10.3 | -1.9 | -8.21 | |||||
Gross Profit, 1 Yr. Growth % | 15.24 | 8.49 | -15.52 | -1.44 | -5.27 | |||||
EBITDA, 1 Yr. Growth % | 36.67 | 16.89 | -40.02 | -4.98 | -18.44 | |||||
EBITA, 1 Yr. Growth % | 45.64 | 18.99 | -47.15 | -10.77 | -26.71 | |||||
EBIT, 1 Yr. Growth % | 45.46 | 18.02 | -48.89 | -11.59 | -28.33 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 313.07 | -16.24 | -58.06 | -59.5 | -377.02 | |||||
Net Income, 1 Yr. Growth % | 319.59 | -16.72 | -57.91 | -61.23 | -390.51 | |||||
Normalized Net Income, 1 Yr. Growth % | 48.64 | 17.66 | -50.29 | -19.21 | -33.56 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 318.82 | -15.92 | -57.4 | -61.29 | -391.67 | |||||
Accounts Receivable, 1 Yr. Growth % | 42.55 | -4.29 | -10.87 | 18.94 | -11.41 | |||||
Inventory, 1 Yr. Growth % | 21.48 | 16.57 | 2.02 | -26.99 | -4.64 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.07 | 2.89 | 8.2 | -0.14 | 3.12 | |||||
Total Assets, 1 Yr. Growth % | 23.56 | -4.83 | 11.98 | -7.42 | -8.23 | |||||
Tangible Book Value, 1 Yr. Growth % | -433.67 | -45.11 | 597.21 | -19.62 | 0.84 | |||||
Common Equity, 1 Yr. Growth % | 53.93 | -7.71 | -0.09 | -4.85 | -27.27 | |||||
Cash From Operations, 1 Yr. Growth % | 59.25 | -16.28 | -43.06 | 36.34 | -46.1 | |||||
Capital Expenditures, 1 Yr. Growth % | 2.25 | 63.27 | -3.56 | -8.37 | -34.49 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 95.78 | -28.87 | -177.02 | -206.45 | 4.22 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 89.41 | -27.82 | -164.76 | -238.7 | 2.9 | |||||
Dividend Per Share, 1 Yr. Growth % | 48.92 | 12.56 | 10.73 | 2.33 | -35.23 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 4.45 | 11.39 | -0.94 | -6.19 | -5.11 | |||||
Gross Profit, 2 Yr. CAGR % | 3.81 | 11.82 | -4.28 | -8.76 | -3.37 | |||||
EBITDA, 2 Yr. CAGR % | 8.18 | 25.58 | -17.07 | -25.07 | -11.98 | |||||
EBITA, 2 Yr. CAGR % | 9.07 | 30.63 | -21.57 | -31.9 | -19.16 | |||||
EBIT, 2 Yr. CAGR % | 8.2 | 29.99 | -23.23 | -33.35 | -20.42 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 26.59 | 86 | -40.73 | -58.79 | 5.91 | |||||
Net Income, 2 Yr. CAGR % | 26.8 | 86.93 | -40.8 | -59.6 | 6.12 | |||||
Normalized Net Income, 2 Yr. CAGR % | 6.12 | 30.37 | -24.44 | -37.19 | -26.76 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 27.13 | 87.66 | -40.15 | -59.39 | 6.26 | |||||
Accounts Receivable, 2 Yr. CAGR % | -3.59 | 16.8 | -7.64 | 2.96 | 2.65 | |||||
Inventory, 2 Yr. CAGR % | 11.75 | 19 | 9.05 | -13.69 | -16.56 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 47.02 | 2.98 | 5.51 | 3.94 | 1.48 | |||||
Total Assets, 2 Yr. CAGR % | 29.23 | 8.44 | 3.23 | 1.82 | -7.83 | |||||
Tangible Book Value, 2 Yr. CAGR % | -29.48 | 35.34 | 95.63 | 136.74 | -9.97 | |||||
Common Equity, 2 Yr. CAGR % | 17.52 | 19.19 | -3.98 | -2.5 | -16.81 | |||||
Cash From Operations, 2 Yr. CAGR % | 20.11 | 15.47 | -30.95 | -11.89 | -14.28 | |||||
Capital Expenditures, 2 Yr. CAGR % | -7.47 | 29.2 | 25.48 | -6 | -22.53 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 18.6 | 17.26 | -24.65 | -10.95 | 5.31 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 18.41 | 16.22 | -30.47 | -6.75 | 19.45 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.33 | 29.47 | 11.64 | 6.44 | -18.59 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.82 | 6.07 | 3.63 | -1.26 | -6.87 | |||||
Gross Profit, 3 Yr. CAGR % | 4.5 | 5.32 | 1.84 | -3.33 | -7.61 | |||||
EBITDA, 3 Yr. CAGR % | 9.85 | 10.63 | -2.44 | -13.08 | -22.93 | |||||
EBITA, 3 Yr. CAGR % | 10.98 | 11.83 | -4.07 | -17.96 | -30.22 | |||||
EBIT, 3 Yr. CAGR % | 10.49 | 10.91 | -5.48 | -19.35 | -31.73 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 37.04 | 10.31 | 13.22 | -47.8 | -22.22 | |||||
Net Income, 3 Yr. CAGR % | 37.33 | 10.22 | 13.72 | -48.59 | -22.03 | |||||
Normalized Net Income, 3 Yr. CAGR % | 10.32 | 9.34 | -6.2 | -22.55 | -36.02 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 38.22 | 10.76 | 14.47 | -48.24 | -21.65 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.6 | -3.82 | 6.74 | 0.49 | -2.07 | |||||
Inventory, 3 Yr. CAGR % | 15.68 | 13.33 | 13.05 | -4.6 | -10.78 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 34.85 | 30.53 | 4.69 | 3.59 | 3.67 | |||||
Total Assets, 3 Yr. CAGR % | 20.47 | 16.7 | 9.61 | -0.45 | -1.65 | |||||
Tangible Book Value, 3 Yr. CAGR % | -23.93 | -35.13 | 133.74 | 45.44 | 78.13 | |||||
Common Equity, 3 Yr. CAGR % | 8.92 | 8.42 | 12.38 | -4.27 | -11.57 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.33 | 6.5 | -8.77 | -13.38 | -25.21 | |||||
Capital Expenditures, 3 Yr. CAGR % | 0.42 | 11.81 | 17.2 | 12.99 | -16.66 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 13.89 | -0.29 | 3.16 | -15.6 | -6.16 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 13.74 | 0.1 | -3.27 | -12.65 | -3.65 | |||||
Dividend Per Share, 3 Yr. CAGR % | 11.83 | 11.74 | 22.9 | 8.45 | -9.8 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.56 | 8.45 | 3.06 | 0.98 | 0.04 | |||||
Gross Profit, 5 Yr. CAGR % | 6.41 | 7.39 | 0.88 | -0.55 | -0.27 | |||||
EBITDA, 5 Yr. CAGR % | 11.29 | 12.82 | -2.02 | -5.32 | -6.29 | |||||
EBITA, 5 Yr. CAGR % | 12.3 | 14.19 | -3.63 | -8.27 | -10.31 | |||||
EBIT, 5 Yr. CAGR % | 11.71 | 13.61 | -4.71 | -9.51 | -11.65 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 20.73 | 13.9 | -1.99 | -25.6 | 10.24 | |||||
Net Income, 5 Yr. CAGR % | 20.82 | 13.86 | -1.91 | -26.23 | 10.62 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.57 | 13.59 | -5.42 | -12.38 | -14.92 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 21.35 | 14.35 | -1.11 | -25.86 | 11.11 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.23 | 3.15 | -0.48 | -1.16 | 5.08 | |||||
Inventory, 5 Yr. CAGR % | 14.66 | 14.57 | 12.98 | 1.63 | 0.12 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 23.07 | 22.44 | 22.24 | 19.16 | 3.39 | |||||
Total Assets, 5 Yr. CAGR % | 18.96 | 12.57 | 13.25 | 10.5 | 2.27 | |||||
Tangible Book Value, 5 Yr. CAGR % | -20.03 | -20.65 | 10.99 | 8.88 | 59.59 | |||||
Common Equity, 5 Yr. CAGR % | 11.14 | 4.98 | 3.56 | 3.91 | -0.36 | |||||
Cash From Operations, 5 Yr. CAGR % | 15.21 | 11.17 | -7.54 | -1.28 | -11.02 | |||||
Capital Expenditures, 5 Yr. CAGR % | 3.94 | 15.59 | 9.78 | 4.32 | -0.68 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 15.94 | 8.67 | -3.63 | -3.47 | 3.91 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 16.07 | 8.75 | -6.74 | -1.51 | 5.12 | |||||
Dividend Per Share, 5 Yr. CAGR % | 12.67 | 12.04 | 11.76 | 9.59 | 4.23 |
- Stock Market
- Equities
- EL Stock
- Financials Estee Lauder
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















